Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Lunglife Ai Inc | LSE:LLAI | London | Ordinary Share | ORD USD0.0001 (DI) |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 8.75 | 25,000 | 08:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 8.50 | 9.00 | 8.75 | 8.75 | 8.75 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 08:05:03 | O | 12,500 | 8.75 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/11/2024 | 07:00 | UK RNS | LungLife AI, INC Operational update |
| 15/11/2024 | 07:00 | UK RNS | LungLife AI, INC Block listing Interim Review |
| 25/10/2024 | 06:00 | UK RNS | LungLife AI, INC Directorate Change |
| 22/10/2024 | 06:00 | UK RNS | LungLife AI, INC Cancellation & Reissue Share Options, PDMR Notice |
| 04/10/2024 | 06:00 | UK RNS | LungLife AI, INC Options Cancellation and Re-issuance |
| 02/10/2024 | 06:00 | UK RNS | LungLife AI, INC LungLB® publication in peer-reviewed journal |
| 02/9/2024 | 06:00 | UK RNS | LungLife AI, INC Data Supporting LungLB to be Presented at the AMP |
| 22/8/2024 | 13:29 | ALNC |  IN BRIEF: LungLife AI optimistic for LungLB as interim loss narrows |
| 22/8/2024 | 06:00 | UK RNS | LungLife AI, INC Half-year Report |
| 16/8/2024 | 10:57 | ALNC | LungLife AI hails progress in making LungLB test more accessible |
Lunglife Ai (LLAI) Share Charts1 Year Lunglife Ai Chart |
|
1 Month Lunglife Ai Chart |
Intraday Lunglife Ai Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 19/11/2024 | 11:01 | LungLife AI - ground breaking lung cancer diagnostics | 87 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 08:05:04 | 8.75 | 12,500 | 1,093.75 | O |
| 08:00:03 | 8.75 | 12,500 | 1,093.75 | O |
| Top Posts |
|---|
Posted at 11/3/2024 13:25 by joseph moran The spread is really small at the moment. The system will not let me sell, the traders have to execute the order.However I can buy for £0.289 the quoted sell price is £0.284 Never known such a small spread on this stock. |
Posted at 07/3/2024 16:36 by ohisay PI's look like they are out of the loop .Unless that changes the share price is fathomless. |
Posted at 02/1/2024 08:25 by brummy_git LungLife's patented Circulating Tumour Cell blood test (LungLB) successfully passes its pivotal 425 person, 17 site, validation study (commenced Feb’22) with flying colours.All the details here. |
Posted at 29/12/2023 08:23 by adorling About time Management put out an RNS to say they expect to release trial results soon to stop this relentless decline. The only positive is when they do publish them the illiquidity will drive the price up very steeply as people scramble to get back in having sold out previously. It went from just over 22p to 120p last time so I would settle for a 6-bag on good news! |
Posted at 29/12/2023 08:22 by adorling What chance of news in the next few weeks? |
Posted at 21/12/2023 06:58 by hatfullofsky They would release the results (which I expect to mirror the earlier study results) before any raise as that would generate lots more interest. Price may spike but it would be a discounted placing on the spiked price, probably around these levels.I do agree that it is an illiquid stock, which is only available on certain platforms. |
Posted at 20/12/2023 17:23 by donk7 Birmingham, has your pal Justin been knocking these out recently? Justin is an impressive small-cap stock picker but incredibly opaque regarding his buys, sells and trading intentions. I'm not sure that is the right way for someone who promotes his often illiquid stocks so forcefully. You can't get much more illiquid than LLAI.The issue with LungLife is that they will need to raise funds. That's no secret. It's not an easy market to do that and I'd assume those willing to fund will only want to come in before results rather than after a potential decent rise post positive results. No guarantees the results will be good but I'd imagine they would be decent. So my guess is a placing followed by results. I don't hold as it is too illiquid but it's one to watch. If they do a placing then hopefully that will make it less liquid. |
Posted at 24/10/2023 11:01 by deanmatlazin I am eagerly waiting for the result to come out. Positive result, with potential revenue between $3billions to $6 billions and the share also traded in US, another 10 bagger in the making |
Posted at 26/9/2023 12:57 by theclangers how do you go about buying shares in this company, the only option that seems available to me, is to use a market order, basically it means, buy at the best available price, so how can the MM be trusted to sell me some, that's not above the offer price? So If I want in, do I have to trust the MM not to rip me off? |
Posted at 13/8/2023 11:48 by rai1965 Since there’s posts. Have you guys seen what’s happening to the share price. I haven’t taken a position yet. I’m wondering if it’s too late or still plenty of upside to come.Have done my DD, this could be a life changing project. All advice/comments appreciated. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
